The entries of “Technologies made in Vienna” are displayed in the project language.
Technologies from Vienna
Panoptes Pharma Ges.m.b.H.
Diseases of the eye and adnexaPanoptes Pharma is a clinical stage company developing small molecule drugs for eye diseases, in particular for autoimmune uveitis, dry eye disease and adenoviral conjunctivitis.
Our lead program, PaniJect, has successfully finished an open label phase 1b/2a study in patients with non-infectious uveitis.
PaniJect was highly effective in improving vision and proofed to be excellently tolerable.
For Panoptes’ ocular surface program, which is developed for the indication dry eye disease, a clinical phase 1 study is currently ongoing.
Kontakt Wirtschaftsagentur Wien
Information and networking are co-funded by the European Fund for regional development as part of the „IC3 Innovation by Co-Operation, Co-Creation and Community Building“ project. Additional information on the IWB/EFRE funding programme